Hematopoietic Stem Cell TransplantationNCT03842735
Physical Activity in Children During Hematopoietic Stem Cells Transplantation (HSCT)
A study testing exercise and rehabilitation counselling and rehabilitation counselling in people with Hematopoietic Stem Cell Transplantation and Child, run by A.O.U. Città della Salute e della Scienza at 1 site in Italy.
Trial summary
This interventional study was designed to assess the validity and the impact of a rehabilitation program on pediatric cancer patients undergoing hematopoietic stem cells transplantation (HSCT). Each participant will be randomly assigned to either an experimental or control (counseling rehabilitation care) group. Read more about this study
- Who is it for?
- Ages 6 months to 18 years
- Conditions the study is for
- Hematopoietic Stem Cell Transplantation, Child, Adolescent
- What is being tested?
- exercise and rehabilitation counselling and rehabilitation counselling
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 1 siteItaly
- Study dates
- 23 May 2016to 28 Feb 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 months to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- i) being children or adolescents (6 months -18 years old);
- ii) to have a diagnosis of oncological or hematological disease;
- iii) receiving an autologous or allogeneic HSCT;
- iv) to have spoken and written Italian language comprehension, both by children/adolescents and by parents.
Who cannot join
- i) to be affected by cognitive difficulties that preclude to the program's participation;
- ii) to be already undergoing rehabilitation before the entrance in the Transplantation Stem Cell Unit (TSCU).
Trial locations and contacts
1 site in 1 country.
Italy1 site
A.O.U. Città della Salute e della Scienza - Regina Margherita children hospital
Turin, 10126
About this study
Official title: Promotion of Physical Activity for Children and Adolescents Undergoing Hematopoietic Stem Cells Transplantation (HSCT) During the In-patient Phase
This interventional study was designed to assess the validity and the impact of a rehabilitation program on pediatric cancer patients undergoing hematopoietic stem cells transplantation (HSCT). Each participant will be randomly assigned to either an experimental or control (counseling rehabilitation care) group. The experimental group participate in an inpatient rehabilitation program for the duration of HSCT pathway. The program include standardized activities for 5 days a week in the child's room or in a pediatric gym at the hospital.
Read the detailed description
BACKGROUND Hematopoietic stem cell transplantation (HSCT) is a potentially curative option for many diseases, such as hematologic malignancies and refractory solid tumors among children and adolescents. This procedure led to considerable improvement in survival rates, but also contributed to the development of late effects. Due to the severity of conditioning regimen, length of isolation and hospitalization period, weakness related to immunosuppression and drug toxicities, physical, cognitive and psychosocial functions are severely impaired. HSCT recipients may report impairments in cardiorespiratory fitness (fatigue), muscle bulk and strength, immunologic recovery, neuropsychological functions, functional abilities and autonomy with an undeniable decline of quality of life (QoL). Recently pediatric oncological research attentions have been directed to reduction of the impact of these side effects and to improvement of QoL, both during and after cancer treatment. The published studies about the effects of rehabilitation care, in pediatric population undergoing HSCT show how rehabilitation, which consists in structured and adapted different therapeutic activities, is safe and feasible. In particular studies conducted on the inpatient phase for HSCT report how the execution of a low intensity level of activity doesn't have any bad effect on immunological recovery, positively affects BMI, gives benefits on general health status, improves QoL, protects from depressive symptoms by promoting a healthy lifestyle during survivorship. Moderate exercise in a chronic graft-versus-host disease (cGVHD) murine model receiving total body irradiation (TBI) and immunosuppression can reduce clinical severity scores, blood interleukine-4 (IL-4) and tumor necrosis factor α levels while increasing survival, physical fitness, circulating B220 and cluster of differentiation 4 (CD4) lymphocytes. Finally, rehabilitation can improve immune function which has an impact on cancer control. Pediatric Oncohaematology Department of "Regina Margherita" Children's Hospital in Turin ["A.O.U. Città della Salute e della Scienza"] is one of the most important structure in Italy for pediatric HSCT. In the year 2016, 47 patients underwent HSCT: 25 of them were less than 11 years old and 22 were older than 11 years. In 2017, until the month of August, 25 patients were transplanted: 12 of them were less than 11 years old and 13 were older than 11 years. The in-patient phase lasted for a medium time of 40 days. From a recent review of the Department, in the period between March 2010 and November 2015, 207 children and adolescent patients benefited of a rehabilitation treatment, 42 of these during and after hospitalization for HSCT. However, to date rehabilitation programs have been implemented in a purely personalized perspective thus ignoring primary methodological issues (e.g., absence of a control group) which would allow an appropriate evaluation of outcomes generalizable to the target population. Therefore, rigorous interventions are mandatory in order to prevent future long-term treatment effects, to improve general health state of these patients and to share evidence-based guidelines for the optimal design for rehabilitation care in pediatric oncology.
EXPERIMENTAL PROJECT Starting from literature data on benefits of participation to a rehabilitation program for subjects undergoing HSCT, the current research intends to propose a project in a prevention perspective aim at the promotion of healthy life style for children and adolescents.
Procedures According to the difficulties reported in other studies that had both exercise group (EG) and control group (CG) patients recovery at the same time, and since this led to inevitable contamination between these two groups, investigators established that eligible patients who provided consent will be assigned to one of the two groups according to a "cluster time" selection model. The study it has been approved by the hospital's Ethical Committee. Written informed consent will be obtain from the participants or from their parents/guardians for patients under eighteen.
Exercise Intervention The study is presented to eligible patients and to their caregivers by a Development Neuro and Psychomotor Therapist in an interview. The interview regards: 1) problems that may occur during the HSCT procedure; 2) the importance of rehabilitation during the recovery to limit side effects; 3) presentation of the study design and procedures; 4) submission of the informed consensus. After having obtained the consensus, patients are assigned to the EG or the CG, according to the methodology previously explained. Subjects receive information booklets containing practical rehabilitation instructions, expressed in both text and illustrations, differentiated by the three identified age ranges (0-4, 5-12, 13-18). The content of booklets varies between EG and CG, since in the first case it contains both exercise and RCI, while for CG it regards only on RCI.
EXPERIMENTAL GROUP: The intervention consists in a standardized PE and RCI. PE is done 5 days/week (2 days in autonomy by the patient with parents support and 3 days supervised). Each session lasts 30 minutes and this is supervised by one therapist for all patients. Children aged less than 5 years make activities directed to sustain and promote their neuro-psychomotor development and muscle strength (e.g. to sit in the infant seat, playing in sitting position without support, playing on the floor and to crawl). Patients belonging to the other two age ranges are enrolled in an exercise programme (EP) composed by three different types of exercises, each carried out for 10 minutes per session: muscle strength exercises for upper and lower extremities preceded by warming up, aerobic exercises and stretching. For children aged 5-12 years activities are based principally on games (e.g. games with the ball, with circles and bricks, etc.), while structured exercises are proposed to adolescents (e.g. using weights, treadmills or exercise bikes); in both groups, the active videogames of Nintendo Wii(™) Fit is used to promote aerobic training. The EP is done only if the patient had platelets > 20000 and Hb > 8.0. Patients belonging to the upper age ranges also benefit from RCI, which has to be followed daily, and where some practical advice are given on how to adopt an active lifestyle during the recovery (e.g., getting up to go to the bathroom, getting up to move to the window to talk with visitors, sit on chair to have school lessons).
Parents record daily their child's EP and RCI activities in appropriate grids, and adolescents filled them in themselves.
CONTROL GROUP: Parents of children who belonged to the 0-4 years old age range CG receive a booklet with some RCI on how to reduce the time spent in bed and to propose different kinds of activities useful to sustain their development, according to the functional level of their child. Children who aged more than 5 years and adolescents of the CG receive the same part of the pamphlets given to the EG, containing written and illustrated indications of the RCI. The RCI has to be followed daily. Parents are required to record in appropriate grids their child's daily activities and adolescents filled them in themselves. The therapist goes 3 times/week to check that the diary has been filled in correctly.
EXPECTED RESULTS (experimental group vs control group): - Stable level of gross motor skills, functional motility, resistance to the walking and muscular strength from T0 and T1; - Stable level in passive articular movement in tibial artery dorsiflexion from T0 and T1; - Stable level of muscular elasticity from T0 and T1; - High perception of QoL and less fatigue from T0 and T1; - Improvement in immune functions; - Positive association between food intake and program participation.
FUTURE APPLICATIONS TO HEALTH The current project seeks to obtain not only important health and clinical benefits for patients undergoing HSCT in terms of late diseases reducing (e.g., obesity), but it will also underline new important association between exercise and biological system useful to find new insight for antitumor mechanisms. Also the need to improve several rehabilitation issues will be showed. For instance, the project will allow to focus on the importance that all patients have access to rehabilitation options. Actually, there is currently a gap between what investigators know from research, and what health care professionals, are implementing in pediatric cancer care. In Italy, for instance, the possibility to benefit of rehabilitation care is still poor because of the absence of services and facilities in several centres of pediatric oncology. So, to pay attention to these unmet needs will be the first step towards the reduction of the financial burden of hospitalization because of late effects problems and secondary disease some of which can be prevented with an appropriate rehabilitation program.
- Conditions
- Hematopoietic Stem Cell Transplantation, Child, Adolescent
- Being tested
- exercise and rehabilitation counselling, rehabilitation counselling
- Keywords
- Physiotherapy, Rehabilitation, Exercise
- Medical subject headings
- Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
exercise and rehabilitation counsellingOther
Also called rehabilitation
The intervention consists in a standardized physical exercise (PE) and rehabilitation counselling indications (RCI). PE is done 5 days/week (2 days in autonomy by the patient with parents support and 3 days supervised). Each session lasts 30 minutes and this is supervised by one therapist for all patients. Patients are enrolled in an EP composed by three different types of exercises, each carried out for 10 minutes per session: muscle strength exercises for upper and lower extremities preceded by warming up, aerobic exercises and stretching. The kind of exercise is differentiated by age range (children, 5-12 years and adolescents, 13-18 years).
rehabilitation counsellingBehavioural
RCI, which have to be followed daily, consist in some practical advice was given on how to adopt an active lifestyle during the recovery (e.g., getting up to go to the bathroom, getting up to move to the window to talk with visitors, sit on chair to have school lessons).
| Study group | Role | What they receive |
|---|---|---|
| exercise and rehabilitation counselling | Experimental | Subjects enrolled in exercise group make physical exercises and receive rehabilitative counselling indications Receives: Other: exercise and rehabilitation counselling; Behavioral: rehabilitation counselling |
| rehabilitation counselling | Other | Subjects enrolled in exercise group only receive rehabilitative counseling indications. Receives: Behavioral: rehabilitation counselling |
What is being measured
The primary outcome is the main question the study is designed to answer.
change in global motor skills level
The Gross Motor Function Measure (GMFM), version -88 for children who aged between 0-4 years, and version-Acute Lymphoblastic Leukemia (ALL) for older subjects. The GMFM-88 is composed by 88 items, while the GMFM-ALL is composed by 21 items. Each item can be scored as 0, 1, 2, 3, or "not tested". Scoring key: 0 - does not initiate, 1 - initiates, 2 - partially completes, and 3 - completed. The total score for GMFM-88 can be between 0 and 264, while for the GMFM-ALL can vary from 0 to 63.
Measured: this outcome it is measured in the week before HSCT [Time 0] and post hematopoietic stem cells transplantation (HSCT), after the discharge from stem cells unit (SCU), at an average of 40 days after Time 0 [Time 1]
change in range of passive ankle dorsiflexion
Goniometer
Measured: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
rate of immune cells recovery
blood counts of leukocytes, monocytes, and lymphocytes and main lymphocyte subpopulations and dendritic cells
Measured: this outcome it is measured 35 days after the first day of infusion ("day zero")
participation rate at the exercise program
Parents are required to record in appropriate grids their child's daily activities and adolescents fill them in themselves. The therapist goes 3 times/week to check that the diary is filled in correctly. This outcome it is measured daily during the stay in the SCU.
Measured: 24 hours
adhesion rate to rehabilitative counselling indications
Parents are required to record in appropriate grids their child's daily activities and adolescents fill them in themselves. The therapist goes 3 times/week to check that the diary is filled in correctly. This outcome it is measured daily during the stay in the SCU.
Measured: 24 hours
Secondary outcomes (6)
change in functional motility level
Time Up and Go Test (TUG); it is measured only in children who aged more than 5 years.
Measured: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
change in tibialis anterior and quadriceps muscles strength level
Medical Research Council Scale (MRC). This method involves testing key muscles from the upper and lower extremities against the examiner's resistance and grading the patient's strength on a 0 to 5 scale accordingly:
0 No muscle activation
- Trace muscle activation, such as a twitch, without achieving full range of motion
- Muscle activation with gravity eliminated, achieving full range of motion
- Muscle activation against gravity, full range of motion
- Muscle activation against some resistance, full range of motion
- Muscle activation against examiner's full resistance, full range of motion It is measured only in children who aged more than 5 years.
Measured: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
change in flexibility level of the lower back and hamstring muscles
Seat and Reach Test; it is measured only in children who aged more than 5 years.
Measured: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
change in functional exercise capacity level
Two Minute Walk Test; it is measured only in children who aged more than 5 years.
Measured: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
change in fatigue level
PedsQL Multidimensional Fatigue Scale. The PedsQL is an interview where item Scaling is based on 5-point Likert scale from 0 (Never) to 4 (Almost always).Items are reversed scored and linearly transformed to a 0-100 scale as follows:
0=100, 1=75, 2=50, 3=25, 4=0. Total Score: Sum of all the items over the number of items answered.
Measured: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
change of quality of life level: PedsQL Cancer Module
PedsQL Cancer Module
Measured: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Feb 2019
- Study start23 May 2016
- Primary completion31 Dec 2019
- Study completion28 Feb 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (13)Papers the sponsor has linked to this study.
- Other trials for Hematopoietic Stem Cell TransplantationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Crossover
- Model description
- Eligible patients who provided consent were assigned to one of the two groups according to a "cluster time" selection model. The methodology was discussed and agreed with expert methodologists of the A.O.U. Città della Salute e della Scienza research group and based assignation to the two groups according to the time of hospitalization: EG enrollment May 2016-December 2016, March 2017-May 2017, November 2017-June 2018 and CG enrollment January 2017-February 2017, June 2017-October 2017, July 2018-August 2018.
- Masking
- None (open label)
- Enrolment
- 80 participants (actual)
Sponsor and investigators
- Lead sponsor
- A.O.U. Città della Salute e della Scienza
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Francesca Rossi, A.O.U. Città della Salute e della Scienza
- Investigators
- Francesca Rossi, Dr, Principal investigator, A.O.U. Città della Salute e della Scienza - OIRM, Turin, Italy
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03842735
- Sponsor's protocol ID
- PHYSICALACTIVITYHSCT0-18YSIPP
- Status last verified
- Mar 2021
- First submitted
- 29 Jan 2019
- Last updated
- 22 Mar 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Rossi F, Coppo M, Zucchetti G, Bazzano D, Ricci F, Vassallo E, Nesi F, Fagioli F. Rehabilitative intervention during and after pediatric hematopoietic stem cell transplantation: An analysis of the existing literature. Pediatr Blood Cancer. 2016 Nov;63(11):1895-904. doi: 10.1002/pbc.26114. Epub 2016 Jul 13.
PubMed 27409063Fiuza-Luces C, Soares-Miranda L, Gonzalez-Murillo A, Palacio JM, Colmenero I, Casco F, Melen GJ, Delmiro A, Moran M, Ramirez M, Lucia A. Exercise benefits in chronic graft versus host disease: a murine model study. Med Sci Sports Exerc. 2013 Sep;45(9):1703-11. doi: 10.1249/MSS.0b013e31828fa004.
PubMed 23954992Fiuza-Luces C, Gonzalez-Murillo A, Soares-Miranda L, Martinez Palacio J, Colmenero I, Casco F, Melen G, Moran M, Lucia A, Ramirez M. Effects of exercise interventions in graft-versus-host disease models. Cell Transplant. 2013;22(12):2409-20. doi: 10.3727/096368912X658746. Epub 2012 Oct 31.
PubMed 23127525Timmons BW, Cieslak T. Human natural killer cell subsets and acute exercise: a brief review. Exerc Immunol Rev. 2008;14:8-23.
PubMed 19203081Chamorro-Vina C, Ruiz JR, Santana-Sosa E, Gonzalez Vicent M, Madero L, Perez M, Fleck SJ, Perez A, Ramirez M, Lucia A. Exercise during hematopoietic stem cell transplant hospitalization in children. Med Sci Sports Exerc. 2010 Jun;42(6):1045-53. doi: 10.1249/MSS.0b013e3181c4dac1.
PubMed 19997035Rosenhagen A, Bernhorster M, Vogt L, Weiss B, Senn A, Arndt S, Siegler K, Jung M, Bader P, Banzer W. Implementation of structured physical activity in the pediatric stem cell transplantation. Klin Padiatr. 2011 May;223(3):147-51. doi: 10.1055/s-0031-1271782. Epub 2011 Apr 1.
PubMed 21462101Hayes S, Davies PS, Parker T, Bashford J, Newman B. Quality of life changes following peripheral blood stem cell transplantation and participation in a mixed-type, moderate-intensity, exercise program. Bone Marrow Transplant. 2004 Mar;33(5):553-8. doi: 10.1038/sj.bmt.1704378.
PubMed 14716346Chamorro-Vina C, Guilcher GM, Khan FM, Mazil K, Schulte F, Wurz A, Williamson T, Reimer RA, Culos-Reed SN. EXERCISE in pediatric autologous stem cell transplant patients: a randomized controlled trial protocol. BMC Cancer. 2012 Sep 10;12:401. doi: 10.1186/1471-2407-12-401.
PubMed 22963378Tanir MK, Kuguoglu S. Impact of exercise on lower activity levels in children with acute lymphoblastic leukemia: a randomized controlled trial from Turkey. Rehabil Nurs. 2013 Jan-Feb;38(1):48-59. doi: 10.1002/rnj.58. Epub 2012 Oct 18.
PubMed 23365005Hartman A, Hop W, Takken T, Pieters R, van den Heuvel-Eibrink M. Motor performance and functional exercise capacity in survivors of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013 Mar;60(3):494-9. doi: 10.1002/pbc.24243. Epub 2012 Jun 28.
PubMed 22745035Moyer-Mileur LJ, Ransdell L, Bruggers CS. Fitness of children with standard-risk acute lymphoblastic leukemia during maintenance therapy: response to a home-based exercise and nutrition program. J Pediatr Hematol Oncol. 2009 Apr;31(4):259-66. doi: 10.1097/MPH.0b013e3181978fd4.
PubMed 19346877Braam KI, van der Torre P, Takken T, Veening MA, van Dulmen-den Broeder E, Kaspers GJ. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer. Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3.
PubMed 27030386Rossi F, Zucchetti G, Esposito M, Berchialla P, Sciannameo V, Vassallo E, Saglio F, Chamorro Vina C, Scarrone S, Vittorini R, Fagioli F. Rehabilitation in children and adolescents undergoing stem cell transplantation: A pilot study focused on motor performance. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13711. doi: 10.1111/ecc.13711. Epub 2022 Sep 28.
PubMed 36168857
Study at a glance
From the registry record, last updated by the sponsor on 22 Mar 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Promotion of Physical Activity for Children and Adolescents Undergoing Hematopoietic Stem Cells Transplantation (HSCT) During the In-patient Phase
- ClinicalTrials.gov ID
- NCT03842735
- Acronym / sponsor ID
- PHYSICALACTIVITYHSCT0-18YSIPP
- Conditions
- Hematopoietic Stem Cell Transplantation, Child, Adolescent
- Keywords
- Physiotherapy, Rehabilitation, Exercise
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 80 participants (actual)
- Lead sponsor
- A.O.U. Città della Salute e della ScienzaUniversity, hospital or other
- Study start
- 23 May 2016 (actual)
- Primary completion
- 31 Dec 2019 (actual)
- Study completion
- 28 Feb 2020 (actual)
- First posted
- 15 Feb 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This interventional study was designed to assess the validity and the impact of a rehabilitation program on pediatric cancer patients undergoing hematopoietic stem cells transplantation (HSCT). Each participant will be randomly assigned to either an experimental or control (counseling rehabilitation care) group. The experimental group participate in an inpatient rehabilitation program for the duration of HSCT pathway. The program include standardized activities for 5 days a week in the child's room or in a pediatric gym at the hospital.
Detailed description
BACKGROUND Hematopoietic stem cell transplantation (HSCT) is a potentially curative option for many diseases, such as hematologic malignancies and refractory solid tumors among children and adolescents. This procedure led to considerable improvement in survival rates, but also contributed to the development of late effects. Due to the severity of conditioning regimen, length of isolation and hospitalization period, weakness related to immunosuppression and drug toxicities, physical, cognitive and psychosocial functions are severely impaired. HSCT recipients may report impairments in cardiorespiratory fitness (fatigue), muscle bulk and strength, immunologic recovery, neuropsychological functions, functional abilities and autonomy with an undeniable decline of quality of life (QoL). Recently pediatric oncological research attentions have been directed to reduction of the impact of these side effects and to improvement of QoL, both during and after cancer treatment. The published studies about the effects of rehabilitation care, in pediatric population undergoing HSCT show how rehabilitation, which consists in structured and adapted different therapeutic activities, is safe and feasible. In particular studies conducted on the inpatient phase for HSCT report how the execution of a low intensity level of activity doesn't have any bad effect on immunological recovery, positively affects BMI, gives benefits on general health status, improves QoL, protects from depressive symptoms by promoting a healthy lifestyle during survivorship. Moderate exercise in a chronic graft-versus-host disease (cGVHD) murine model receiving total body irradiation (TBI) and immunosuppression can reduce clinical severity scores, blood interleukine-4 (IL-4) and tumor necrosis factor α levels while increasing survival, physical fitness, circulating B220 and cluster of differentiation 4 (CD4) lymphocytes. Finally, rehabilitation can improve immune function which has an impact on cancer control. Pediatric Oncohaematology Department of "Regina Margherita" Children's Hospital in Turin ["A.O.U. Città della Salute e della Scienza"] is one of the most important structure in Italy for pediatric HSCT. In the year 2016, 47 patients underwent HSCT: 25 of them were less than 11 years old and 22 were older than 11 years. In 2017, until the month of August, 25 patients were transplanted: 12 of them were less than 11 years old and 13 were older than 11 years. The in-patient phase lasted for a medium time of 40 days. From a recent review of the Department, in the period between March 2010 and November 2015, 207 children and adolescent patients benefited of a rehabilitation treatment, 42 of these during and after hospitalization for HSCT. However, to date rehabilitation programs have been implemented in a purely personalized perspective thus ignoring primary methodological issues (e.g., absence of a control group) which would allow an appropriate evaluation of outcomes generalizable to the target population. Therefore, rigorous interventions are mandatory in order to prevent future long-term treatment effects, to improve general health state of these patients and to share evidence-based guidelines for the optimal design for rehabilitation care in pediatric oncology.
EXPERIMENTAL PROJECT Starting from literature data on benefits of participation to a rehabilitation program for subjects undergoing HSCT, the current research intends to propose a project in a prevention perspective aim at the promotion of healthy life style for children and adolescents.
Procedures According to the difficulties reported in other studies that had both exercise group (EG) and control group (CG) patients recovery at the same time, and since this led to inevitable contamination between these two groups, investigators established that eligible patients who provided consent will be assigned to one of the two groups according to a "cluster time" selection model. The study it has been approved by the hospital's Ethical Committee. Written informed consent will be obtain from the participants or from their parents/guardians for patients under eighteen.
Exercise Intervention The study is presented to eligible patients and to their caregivers by a Development Neuro and Psychomotor Therapist in an interview. The interview regards: 1) problems that may occur during the HSCT procedure; 2) the importance of rehabilitation during the recovery to limit side effects; 3) presentation of the study design and procedures; 4) submission of the informed consensus. After having obtained the consensus, patients are assigned to the EG or the CG, according to the methodology previously explained. Subjects receive information booklets containing practical rehabilitation instructions, expressed in both text and illustrations, differentiated by the three identified age ranges (0-4, 5-12, 13-18). The content of booklets varies between EG and CG, since in the first case it contains both exercise and RCI, while for CG it regards only on RCI.
EXPERIMENTAL GROUP: The intervention consists in a standardized PE and RCI. PE is done 5 days/week (2 days in autonomy by the patient with parents support and 3 days supervised). Each session lasts 30 minutes and this is supervised by one therapist for all patients. Children aged less than 5 years make activities directed to sustain and promote their neuro-psychomotor development and muscle strength (e.g. to sit in the infant seat, playing in sitting position without support, playing on the floor and to crawl). Patients belonging to the other two age ranges are enrolled in an exercise programme (EP) composed by three different types of exercises, each carried out for 10 minutes per session: muscle strength exercises for upper and lower extremities preceded by warming up, aerobic exercises and stretching. For children aged 5-12 years activities are based principally on games (e.g. games with the ball, with circles and bricks, etc.), while structured exercises are proposed to adolescents (e.g. using weights, treadmills or exercise bikes); in both groups, the active videogames of Nintendo Wii(™) Fit is used to promote aerobic training. The EP is done only if the patient had platelets > 20000 and Hb > 8.0. Patients belonging to the upper age ranges also benefit from RCI, which has to be followed daily, and where some practical advice are given on how to adopt an active lifestyle during the recovery (e.g., getting up to go to the bathroom, getting up to move to the window to talk with visitors, sit on chair to have school lessons).
Parents record daily their child's EP and RCI activities in appropriate grids, and adolescents filled them in themselves.
CONTROL GROUP: Parents of children who belonged to the 0-4 years old age range CG receive a booklet with some RCI on how to reduce the time spent in bed and to propose different kinds of activities useful to sustain their development, according to the functional level of their child. Children who aged more than 5 years and adolescents of the CG receive the same part of the pamphlets given to the EG, containing written and illustrated indications of the RCI. The RCI has to be followed daily. Parents are required to record in appropriate grids their child's daily activities and adolescents filled them in themselves. The therapist goes 3 times/week to check that the diary has been filled in correctly.
EXPECTED RESULTS (experimental group vs control group): - Stable level of gross motor skills, functional motility, resistance to the walking and muscular strength from T0 and T1; - Stable level in passive articular movement in tibial artery dorsiflexion from T0 and T1; - Stable level of muscular elasticity from T0 and T1; - High perception of QoL and less fatigue from T0 and T1; - Improvement in immune functions; - Positive association between food intake and program participation.
FUTURE APPLICATIONS TO HEALTH The current project seeks to obtain not only important health and clinical benefits for patients undergoing HSCT in terms of late diseases reducing (e.g., obesity), but it will also underline new important association between exercise and biological system useful to find new insight for antitumor mechanisms. Also the need to improve several rehabilitation issues will be showed. For instance, the project will allow to focus on the importance that all patients have access to rehabilitation options. Actually, there is currently a gap between what investigators know from research, and what health care professionals, are implementing in pediatric cancer care. In Italy, for instance, the possibility to benefit of rehabilitation care is still poor because of the absence of services and facilities in several centres of pediatric oncology. So, to pay attention to these unmet needs will be the first step towards the reduction of the financial burden of hospitalization because of late effects problems and secondary disease some of which can be prevented with an appropriate rehabilitation program.
Study design
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Eligible patients who provided consent were assigned to one of the two groups according to a "cluster time" selection model. The methodology was discussed and agreed with expert methodologists of the A.O.U. Città della Salute e della Scienza research group and based assignation to the two groups according to the time of hospitalization: EG enrollment May 2016-December 2016, March 2017-May 2017, November 2017-June 2018 and CG enrollment January 2017-February 2017, June 2017-October 2017, July 2018-August 2018.
| Arm | Type | Receives |
|---|---|---|
| exercise and rehabilitation counselling | Experimental | Other: exercise and rehabilitation counselling, Behavioral: rehabilitation counsellingSubjects enrolled in exercise group make physical exercises and receive rehabilitative counselling indications |
| rehabilitation counselling | Other | Behavioral: rehabilitation counsellingSubjects enrolled in exercise group only receive rehabilitative counseling indications. |
Who may qualify
- Ages
- 6 months to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (4 listed)
- i) being children or adolescents (6 months -18 years old);
- ii) to have a diagnosis of oncological or hematological disease;
- iii) receiving an autologous or allogeneic HSCT;
- iv) to have spoken and written Italian language comprehension, both by children/adolescents and by parents.
Key exclusion criteria (2 listed)
- i) to be affected by cognitive difficulties that preclude to the program's participation;
- ii) to be already undergoing rehabilitation before the entrance in the Transplantation Stem Cell Unit (TSCU).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| exercise and rehabilitation counsellingAlso: rehabilitationThe intervention consists in a standardized physical exercise (PE) and rehabilitation counselling indications (RCI). PE is done 5 days/week (2 days in autonomy by the patient with parents support and 3 days supervised). Each session lasts 30 minutes and this is supervised by one therapist for all patients. Patients are enrolled in an EP composed by three different types of exercises, each carried out for 10 minutes per session: muscle strength exercises for upper and lower extremities preceded by warming up, aerobic exercises and stretching. The kind of exercise is differentiated by age range (children, 5-12 years and adolescents, 13-18 years). | Other | exercise and rehabilitation counselling |
| rehabilitation counsellingRCI, which have to be followed daily, consist in some practical advice was given on how to adopt an active lifestyle during the recovery (e.g., getting up to go to the bathroom, getting up to move to the window to talk with visitors, sit on chair to have school lessons). | Behavioural | exercise and rehabilitation counselling, rehabilitation counselling |
Primary outcome
change in global motor skills level
Time frame: this outcome it is measured in the week before HSCT [Time 0] and post hematopoietic stem cells transplantation (HSCT), after the discharge from stem cells unit (SCU), at an average of 40 days after Time 0 [Time 1]
The Gross Motor Function Measure (GMFM), version -88 for children who aged between 0-4 years, and version-Acute Lymphoblastic Leukemia (ALL) for older subjects. The GMFM-88 is composed by 88 items, while the GMFM-ALL is composed by 21 items. Each item can be scored as 0, 1, 2, 3, or "not tested". Scoring key: 0 - does not initiate, 1 - initiates, 2 - partially completes, and 3 - completed. The total score for GMFM-88 can be between 0 and 264, while for the GMFM-ALL can vary from 0 to 63.
change in range of passive ankle dorsiflexion
Time frame: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
Goniometer
rate of immune cells recovery
Time frame: this outcome it is measured 35 days after the first day of infusion ("day zero")
blood counts of leukocytes, monocytes, and lymphocytes and main lymphocyte subpopulations and dendritic cells
participation rate at the exercise program
Time frame: 24 hours
Parents are required to record in appropriate grids their child's daily activities and adolescents fill them in themselves. The therapist goes 3 times/week to check that the diary is filled in correctly. This outcome it is measured daily during the stay in the SCU.
adhesion rate to rehabilitative counselling indications
Time frame: 24 hours
Parents are required to record in appropriate grids their child's daily activities and adolescents fill them in themselves. The therapist goes 3 times/week to check that the diary is filled in correctly. This outcome it is measured daily during the stay in the SCU.
6 secondary outcomes
change in functional motility level
Time frame: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
change in tibialis anterior and quadriceps muscles strength level
Time frame: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
change in flexibility level of the lower back and hamstring muscles
Time frame: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
change in functional exercise capacity level
Time frame: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
change in fatigue level
Time frame: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
change of quality of life level: PedsQL Cancer Module
Time frame: this outcome it is measured in the week before HSCT [Time 0] and post HSCT, after the discharge from SCU, at an average of 40 days after Time 0 [Time 1]
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Mar 2021.
- Background: PubMed 27409063Rossi F, Coppo M, Zucchetti G, Bazzano D, Ricci F, Vassallo E, Nesi F, Fagioli F. Rehabilitative intervention during and after pediatric hematopoietic stem cell transplantation: An analysis of the existing literature. Pediatr Blood Cancer. 2016 Nov;63(11):1895-904. doi: 10.1002/pbc.26114. Epub 2016 Jul 13.
- Background: PubMed 23954992Fiuza-Luces C, Soares-Miranda L, Gonzalez-Murillo A, Palacio JM, Colmenero I, Casco F, Melen GJ, Delmiro A, Moran M, Ramirez M, Lucia A. Exercise benefits in chronic graft versus host disease: a murine model study. Med Sci Sports Exerc. 2013 Sep;45(9):1703-11. doi: 10.1249/MSS.0b013e31828fa004.
- Background: PubMed 23127525Fiuza-Luces C, Gonzalez-Murillo A, Soares-Miranda L, Martinez Palacio J, Colmenero I, Casco F, Melen G, Moran M, Lucia A, Ramirez M. Effects of exercise interventions in graft-versus-host disease models. Cell Transplant. 2013;22(12):2409-20. doi: 10.3727/096368912X658746. Epub 2012 Oct 31.
- Background: PubMed 19203081Timmons BW, Cieslak T. Human natural killer cell subsets and acute exercise: a brief review. Exerc Immunol Rev. 2008;14:8-23.
- Background: PubMed 19997035Chamorro-Vina C, Ruiz JR, Santana-Sosa E, Gonzalez Vicent M, Madero L, Perez M, Fleck SJ, Perez A, Ramirez M, Lucia A. Exercise during hematopoietic stem cell transplant hospitalization in children. Med Sci Sports Exerc. 2010 Jun;42(6):1045-53. doi: 10.1249/MSS.0b013e3181c4dac1.
- Background: PubMed 21462101Rosenhagen A, Bernhorster M, Vogt L, Weiss B, Senn A, Arndt S, Siegler K, Jung M, Bader P, Banzer W. Implementation of structured physical activity in the pediatric stem cell transplantation. Klin Padiatr. 2011 May;223(3):147-51. doi: 10.1055/s-0031-1271782. Epub 2011 Apr 1.
- Background: PubMed 14716346Hayes S, Davies PS, Parker T, Bashford J, Newman B. Quality of life changes following peripheral blood stem cell transplantation and participation in a mixed-type, moderate-intensity, exercise program. Bone Marrow Transplant. 2004 Mar;33(5):553-8. doi: 10.1038/sj.bmt.1704378.
- Background: PubMed 22963378Chamorro-Vina C, Guilcher GM, Khan FM, Mazil K, Schulte F, Wurz A, Williamson T, Reimer RA, Culos-Reed SN. EXERCISE in pediatric autologous stem cell transplant patients: a randomized controlled trial protocol. BMC Cancer. 2012 Sep 10;12:401. doi: 10.1186/1471-2407-12-401.
- Background: PubMed 23365005Tanir MK, Kuguoglu S. Impact of exercise on lower activity levels in children with acute lymphoblastic leukemia: a randomized controlled trial from Turkey. Rehabil Nurs. 2013 Jan-Feb;38(1):48-59. doi: 10.1002/rnj.58. Epub 2012 Oct 18.
- Background: PubMed 22745035Hartman A, Hop W, Takken T, Pieters R, van den Heuvel-Eibrink M. Motor performance and functional exercise capacity in survivors of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013 Mar;60(3):494-9. doi: 10.1002/pbc.24243. Epub 2012 Jun 28.
- Background: PubMed 19346877Moyer-Mileur LJ, Ransdell L, Bruggers CS. Fitness of children with standard-risk acute lymphoblastic leukemia during maintenance therapy: response to a home-based exercise and nutrition program. J Pediatr Hematol Oncol. 2009 Apr;31(4):259-66. doi: 10.1097/MPH.0b013e3181978fd4.
- Background: PubMed 27030386Braam KI, van der Torre P, Takken T, Veening MA, van Dulmen-den Broeder E, Kaspers GJ. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer. Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3.
- Individual participant dataSharing planned: No
Related trials for Hematopoietic Stem Cell Transplantation
Not yet recruitingObservational study
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
Hematopoietic Stem Cell Transplant
Active, not recruitingPhase 1/2
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Multiple Myeloma
RecruitingEarly Phase 1
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
Hematologic Malignancy
Active, not recruitingPhase 2
Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
RecruitingObservational study
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Leukemia, Lymphoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Francesca Rossi, Dr principal investigator
A.O.U. Città della Salute e della Scienza - OIRM, Turin, Italy
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing exercise and rehabilitation counselling and rehabilitation counselling in people with Hematopoietic Stem Cell Transplantation and Child, run by A.O.U. Città della Salute e della Scienza at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
change in global motor skills level (time frame: this outcome it is measured in the week before HSCT [Time 0] and post hematopoietic stem cells transplantation (HSCT), after the discharge from stem cells unit (SCU), at an average of 40 days after Time 0 [Time 1]). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03842735, which also lists 13 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Mar 2021.